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Background: The risk for obesity is twice as high in people with serious mental illness (SMI) compared to the
general population. Racial and ethnic minority status contribute additional health risks. The aim of this study is to
describe the protocol of a Hybrid Trial Type 1 design that will test the effectiveness and examine the implementation
of a peer-led healthy lifestyle intervention in supportive housing agencies serving diverse clients with serious mental
illness who are overweight or obese.
Methods: The Hybrid Trial Type 1 design will combine a randomized effectiveness trial with a mixed-methods
implementation study. The effectiveness trial will test the health impacts of a peer-led healthy lifestyle intervention
versus usual care in supportive housing agencies. The healthy lifestyle intervention is derived from the Group Lifestyle
Balanced Program, lasts 12 months, and will be delivered by trained peer specialists. Repeated assessments will be
conducted at baseline and at 6, 12, and 18 months post randomization. A mixed-methods (e.g., structured interviews,
focus groups, surveys) implementation study will be conducted to examine multi-level implementation factors and
processes that can inform the use of the healthy lifestyle intervention in routine practice, using data from agency
directors, program managers, staff, and peer specialists before, during, and after the implementation of the
effectiveness trial.
Discussion: This paper describes the use of a hybrid research design that blends effectiveness trial methodologies and
implementation science rarely used when studying the physical health of people with SMI and can serve as a model
for integrating implementation science and health disparities research. Rigorously testing effectiveness and exploring
the implementation process are both necessary steps to establish the evidence for large-scale delivery of peer-led
healthy lifestyle intervention to improve the physical health of racial/ethnic minorities with SMI.
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Obesity and related conditions (e.g., type-2 diabetes (T2D))
disproportionately impact people with serious mental ill-
ness (SMI: e.g., schizophrenia) compared to the general
population [1–4]. Racial/ethnic minority status confers
additional risks. Compared to non-Latino whites with
SMI, Latinos [4–9] and African Americans [10] with SMI
are at higher risk of obesity, metabolic syndrome, and
T2D. Modifiable risk factors for obesity (e.g., physical in-
activity) are more prevalent among low-income African
Americans and Latinos than whites [11] and are key
contributors of excess mortality among people with SMI
[12–14]. Regardless of race/ethnicity, addressing obesity
and overweight in people with SMI is critical, as these
health conditions adversely affect treatment adherence,
relapse, quality of life, and are linked to premature
mortality [2].
Healthy lifestyle interventions can combat overweight/
obesity and lower the risk of T2D and cardiovascular
disease (CVD). The Group Lifestyle Balance (GLB), a
healthy lifestyle intervention derived from the Diabetes
Prevention Program, has proven efficacious for prevent-
ing and delaying T2D and CVD in the general popula-
tion through its impact on weight loss [15–20]. GLB is
an evidence-based intervention delivered in groups that
uses behavioral strategies (e.g., self-monitoring) to sup-
port healthy diet modifications and increase physical ac-
tivity [21]. Among people with SMI, healthy lifestyle
interventions can achieve improvements in body weight,
body mass index (BMI), cardiometabolic indicators, and
quality of life, particularly if they focus on multiple life-
style factors and use behavioral strategies [22–25].
Recent studies show that when lifestyle interventions
are accessible to people with SMI in clinical settings, they
can result in clinically significant weight loss [26, 27]. For
example, participants in the ACHIEVE trial who received
an 18-month behavioral weight-loss intervention in out-
patient psychiatric rehabilitation programs lost 7 lbs on
average and 37.8 % lost ≥ 5 % of their initial weight, com-
pared to 22.7 % of controls [27]. Despite these results,
healthy lifestyle interventions are usually delivered in clin-
ical settings by clinical staff and are rarely available in
other community settings that serve people with SMI
(e.g., housing agencies) due to logistical, access, and staff-
ing barriers. The effectiveness of healthy lifestyle interven-
tions among racial/ethnic minorities with SMI living in
the community also remains unclear. In a systematic lit-
erature review of lifestyle interventions for people with
SMI in the United States (US), minorities represented less
than one fourth of study participants and only one study
(n = 8) included Spanish-speaking Hispanics [22]. More
research has been done recently, but only in clinical set-
tings. A study tested the acceptability and feasibility of a
weight loss program among 43 Latino patients with SMIin an outpatient clinic [28], and the ACHIEVE trial sample
was 38 % black. More work is needed given the growth of
the national racial/ethnic minority population and the per-
sistent health disparities they face.
Peer-led healthy lifestyle intervention for people with SMI
Healthy lifestyle interventions, like GLB, can produce
health benefits for people with SMI as they target modi-
fiable risk factors linked to T2D and CVD [29, 30]. A
key focus of GLB is to achieve ≥ 5 % weight loss, which
yields reductions in morbidity and mortality from T2D
and CVD in people who are overweight or obese. This
level of weight loss raises HDL (“good”) cholesterol and
lowers total and LDL (“bad”) cholesterol, triglycerides,
glucose, and blood pressure [31–33]. GLB also leads to
increased physical activity to the recommended level of
≥ 150 minute/week of moderate activity (e.g., brisk walk-
ing) [34]. This threshold reduces cardiometabolic risk in-
dependent of weight loss [35] and is linked to a 14 %
reduction in risk for all-cause mortality [36]. Given these
health benefits, GLB is being translated to communities
impacted by the obesity and T2D epidemics [37, 38]. A
meta-analysis of 28 US-based effectiveness studies in the
general population examining the impact of GLB pro-
grams found that the average weight loss at 12 months
was 4–5 % and that this outcome was achieved regard-
less of whether GLB was delivered by trained profes-
sionals or community health workers in a group format
[37]. These findings suggest that moving GLB to com-
munity settings serving people with SMI by using a
group format and trained peer specialists is an important
next step that can make GLB more accessible and eco-
nomically feasible without diluting its effectiveness.
Peer specialists are individuals that have personal ex-
periences with health/mental health issues who have
progressed in their recovery and received training to
support others. They are a growing segment of the men-
tal health workforce [39] with more than 30 states in the
US having some level of Medicaid reimbursement for
peer specialists, and this number will grow with the im-
plementation of the Affordable Care Act [40, 41]. Peer-
led interventions have been successfully used in other
health conditions [42–46]. Peer specialists bring credibil-
ity, trust, and hope to people with SMI [47]. Peer spe-
cialists can expose clients to positive and credible role
models who can tap into their own experiences to pro-
vide instrumental, informational, and emotional support;
help translate the health intervention into clients’ daily
activities on ecological and cultural terms; and become
credible “coaches” [48, 49].
Peer-led programs for people with SMI tend to produce
as good or better results than non-peer-led programs,
particularly when peer specialists deliver evidence-based
interventions. Druss et al. [48] found that a peer-led
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ness self-management intervention [42] was superior to
usual care (UC) at 6 months in producing significant
improvements in patients’ activation, primary care visits,
and physical health-related quality of life. Although
these results are promising, peer-led interventions have
not targeted modifiable healthy lifestyle factors that can
reduce obesity and prevent T2D and CVD. Establishing
the effectiveness of Peer GLB in community settings,
like supportive housing, is a logical next step that re-
quires rigorous evaluation.
Why deliver healthy lifestyle interventions in supportive
housing?
Supportive housing refers to programs that provide ac-
cess to affordable community-based housing and flexible
services to address clients’ health and psychosocial needs
[49]. Supportive housing units account for the largest
share (39 %) of the housing inventory dedicated to hous-
ing the homeless in the US [50]. Approximately 80 % of
supportive housing units in the US serve people with
SMI, and this number is growing [51]. Supportive hous-
ing agencies are an ideal setting to deliver healthy life-
style programs for several reasons. First, delivering Peer
GLB at these agencies addresses access barriers as it
brings a health intervention to people’s doorsteps [49].
Second, given the expansion of services supported by
the Affordable Care Act, many supportive housing agen-
cies are moving towards integrating health interventions
into their operations [52, 53]. Third, these agencies
already deliver group-based services (e.g., vocational
classes). Fourth, these agencies serve people with a range
of psychiatric diagnoses and health conditions, thus in-
terventions delivered in these settings will have a broad
reach among the SMI population. Fifth, many supportive
housing agencies employ peer specialists; therefore, a
peer-led healthy lifestyle intervention provides an eco-
nomically feasible approach that fits with their existing
staff. Last, we have found that clients have strong prefer-
ences for bringing peer-led healthy lifestyle interventions
into these agencies’ settings [54].
Conceptual framework
Hybrid designs take on “a dual focus in assessing clinical
effectiveness and implementation bridging the gap be-
tween these two areas of research” [55]. A Hybrid Trial
Type 1 design, as proposed in this study, tests the effects
of a clinical intervention on client-level outcomes, while
exploring multi-level implementation factors that can in-
form the use of the intervention in real-world settings.
Studying how community agencies implement an estab-
lished intervention, even within an effectiveness study,
can advance the translation of research into practice in
several ways. It provides an opportunity to explorelongitudinally how the introduction of a new program
influences and is influenced by agencies’ context. It can
help identify the structures, policies, organizational
characteristics, and processes that facilitate or impede
the use of peer-led health interventions in community
settings. This identification is critical, as staff attitudes
and organizational practices can undermine the integra-
tion of peer-led services within organizations [56–58].
Finally, a hybrid design can generate knowledge neces-
sary to develop implementation strategies that can ac-
company these interventions to enhance their use in
routine practice.
Our study is guided by a multi-level framework (see
Fig. 1) that draws from different implementation theor-
ies [59–61] and posits that the effectiveness of Peer GLB
in supportive housing client-level outcomes will be me-
diated by the fidelity with which the intervention is de-
livered and moderated by several client-level factors.
This entire process occurs within a context composed of
system-level, organizational-level, and staff-level factors
known to influence the implementation of evidence-
based practices [61].
Implementation fidelity
Fidelity is an implementation outcome that captures the
degree to which an intervention is delivered as pre-
scribed [59, 62]. In this study, we focus on three fidelity
elements: 1) adherence: the degree to which components
of Peer GLB are delivered; 2) dose: the number and type
of Peer GLB sessions delivered; 3) participants’ respon-
siveness: the extent to which participants engages and
are satisfied with Peer GLB. Attention to these fidelity
elements has been recommended for implementation re-
search [63] and will allow us to examine the extent to
which peer specialists deliver Peer GLB as specified in
our protocol.
Client-level factors
Our model stipulates that client-level factors will moder-
ate the effectiveness of Peer GLB. Data from the Diabetes
Prevention Program indicate that black women in the life-
style intervention group lost significantly less weight than
other racial/ethnic and gender groups [64]. The use of
antipsychotic medications that cause weight gain can also
attenuate weight loss [2]. In contrast, clients’ positive atti-
tudes toward Peer GLB (e.g., satisfaction) can result in bet-
ter treatment engagement and outcomes.
System-level factors
The delivery of Peer GLB is embedded within a multi-
level context [61]. At the system level, we include factors
beyond supportive housing that affect Peer GLB imple-
mentation, such as reimbursement policies and regula-
tions to employ peer specialists, market pressures due to
Fig. 1 Conceptual framework for effectiveness and implementation research
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centives for wellness programing, and agencies’ leaders’
perceived need for Peer GLB. We explore these system-
level factors in our implementation study as they can help
identify key policies and resources to leverage the imple-
mentation of health interventions in community settings
serving people with SMI.
Organizational-level factors
At the organizational level, we capture the inner context
of housing agencies, such as the organizations’ character-
istics and social context that influence the implementa-
tion, quality, and outcomes of evidence-based practices
[60, 61]. We follow Glisson et al. [60] in their concep-
tualization of organizational social context composed of
three interrelated domains: culture, climate, and work
attitudes. Organizational culture refers to the values and
norms that govern how work is done in an organization
and is characterized as rigid, proficient or resistant [65].
Organizational climate refers to employee perceptions of
the psychological impact of the work environment on
their well-being and functioning in the organization and
is characterized as engaged, functional, or stressful [60].
Work attitudes include the employees’ affective attach-
ments to their jobs and encompass job satisfaction and
commitment to the organization [65]. We include agen-
cies’ recovery orientation [66] as one of our organi-
zational factors given the link between health and
recovery [67]. We capture factors that influence the inte-
gration of peer-led services within organizations, such as
staff attitudes toward peer specialists, role conflicts, andsupervision [56–58]. Understanding how organizational-
level factors shape Peer GLB’s implementation is critical
as implementation occurs in organizations and their
contexts shape how providers adopt new practices [68].
Many organizational factors are also malleable through
strategic interventions.
Staff-level factors
At the staff level, we focus on staff characteristics and at-
titudes towards evidence-based practices (EBPs) and
Peer GLB, as they influence the implementation of prac-
tice innovations. Attitudes toward EBPs consist of four
interrelated dimensions: intuitive appeal of EBPs, likeli-
hood of adopting EBPs if required by the organization,
general openness to learning new practices, and per-
ceived divergence between research-based practices and
clinical experiences [65, 69]. We draw on the work of
Rogers [70] and Damschroder et al. [61] to examine staff
attitudes toward Peer GLB by focusing on key interven-
tion characteristics (e.g., relative advantage) that influ-
ence implementation decisions [70]. Examining how
staff-level factors impact and are impacted by the imple-
mentation of Peer GLB is critical as implementation is
driven by staff behaviors that are influenced by staff
characteristics, attitudes, intentions, and motivations.
Staff-level factors are also shaped by organizational fac-
tors (e.g., culture) and represent a set of proximal deter-
minants of providers’ and peer specialists’ willingness to
adopt new interventions [65, 68]. Taken together, our
model will serve as a guiding framework integrated in all
stages of the research process.
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1. Compare the effectiveness of Peer GLB versus UC in
achieving clinically significant weight loss (≥5 %
weight loss) at 12 and 18 months among
overweight/obese (BMI ≥ 25) clients in supportive
housing agencies.
2. Compare reductions in total weight, waist
circumference, blood pressure, and improvements in
physical activity, self-efficacy, recovery, and quality
of life at 6, 12, and 18 months post randomization
between Peer GLB and UC.
3. Explore whether client-level characteristics (e.g.,
socio-demographics, antipsychotic use, attitudes
toward Peer GLB) moderate Peer GLB’s effectiveness.
4. Identify system-level, organizational-level, and
staff-level factors that facilitate or impede the
implementation of Peer GLB in supportive housing
agencies.
Methods
Overview of hybrid design
We use a Hybrid Trial Type 1 design (see Fig. 2) that
combines a randomized effectiveness trial with a mixed-
methods implementation study. The study has been ap-
proved by the Institutional Review Boards of Columbia
University and the Philadelphia Department of Health.
Study sites
Three supportive housing agencies will serve as our
community partners. The first agency uses a Housing
First model, a SAMHSA-recognized EBP in which cli-
ents are offered an apartment throughout the commu-
nity without requiring them to participate in formal
treatment [71, 72]. By contrast, the other two agencies
follow a treatment-first model in which clients areFig. 2 Hybrid Trial Type 1 designoffered housing in either buildings that they manage or
in apartments throughout the community, on the condi-
tion that they receive mental health services. The differ-
ences in these agencies enhances the wider reach and
applicability of Peer GLB as it enables us to examine
how to translate this intervention in two widely used
supportive housing models.
Randomized effectiveness trial (Aims 1–3)
Recruitment
Trained bilingual research assistants (RAs) will recruit
participants through flyers, word-of-mouth, staff refer-
rals, and presentations at groups and social events at
each study site. For interested participants, RAs will
conduct a face-to-face screening interview to determine
study eligibility, and for those eligible, obtain informed
consent. Eligibility criteria (Table 1) are similar to the
ones used in previous weight loss trials [27, 28] and are
broad in order to capture a sample that resembles ra-
cially/ethnically diverse people with SMI served by sup-
portive housing agencies. RAs will then conduct baseline
interviews face-to-face with eligible participants at their
site within a week of recruitment.
Randomization
A total of 300 clients will be recruited and randomized
to a single-blind randomized effectiveness trial. Within
each of the 3 sites, participants will be randomized 1:1
to Peer GLB or UC, resulting in approximately 50 clients
randomized to Peer GLB and 50 to UC within each site.
Peer GLB groups at each site will begin once 6–8 new
people have been randomized to Peer GLB.
Intervention condition
GLB is a 12-month group-based healthy lifestyle inter-
vention adapted from the original Diabetes Prevention
Table 1 Eligibility criteria for effectiveness trial
Inclusion criteria
Demographics Male or female, 18 years of age or older, of any race/ethnicity, who are English and/or Spanish
speakers and are receiving supportive housing services at the study sites
Mental health diagnosis Chart diagnosis of a serious mental illness (e.g., schizophrenia, bipolar disorder, schizoaffective
disorders, major depression)
Body mass index BMI ≥ 25 (kg/m2)
Informed consent Able and willing to give written informed consent to participate in study
Willingness to obtain medical clearance Able and willing to obtain a medical clearance letter from a primary care physician with
assistance from the study team if randomly assigned to the Peer GLB group
Exclusion criteria
Substance abuse Need for detoxification services at the time of recruitment
Suicidal/Homicidal ideation Pose a danger to self or others at the time of recruitment
Capacity to consent Failed capacity-to-consent questionnaire [88]
Cognitive impairment For participants 65 years or older: screen positive for cognitive impairment based on Mini-cog
clock test [89]
Medical contraindications to participate in
weight loss program
Self-report of any of the following medical conditions that are contraindicated to participation
in a weight loss program: cancer requiring active treatment, liver failure, history of anorexia
nervosa, cardiovascular event (e.g., unstable angina, myocardial infarction) within the past
6 months, walking limitations preventing participation in exercise, history of weight loss surgery
or planning weight loss surgery during study period, and (for female participants) pregnant or
planning a pregnancy during study period.
(Exclusion criteria for participants randomized to the intervention group: primary care physician
confirms that the person has any of the following medical conditions: cancer requiring active
treatment, liver failure, history of anorexia nervosa, cardiovascular event (e.g., unstable angina,
myocardial infarction) within the past 6 months, walking limitations preventing participation
in exercise, history of weight loss surgery or planning weight loss surgery during study period,
and (for female participants) pregnant or planning a pregnancy during study period
GLB Group Lifestyle Balance
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vention Support Center at the University of Pittsburgh
(see http://www.diabetesprevention.pitt.edu/ for more
details about the GLB program). GLB is a goal-based
behavioral intervention to achieve and maintain 7 %
weight loss through modest dietary restrictions and
moderate physical activity up to 150 minutes/week [20].
GLB consists of weekly core group sessions (3 months),
bi-monthly transitional group sessions (3 months), and
monthly maintenance sessions (6 months) delivered in
community settings. Key features include integration of
safe and appropriate nutrition education, physical activ-
ity recommendations, and behavioral change strategies
including the use of self-monitoring tools (e.g., physical
activity logs) with regular feedback, and the incorpor-
ation of problem-solving techniques to reduce barriers
to healthy lifestyles. GLB includes a group facilitator
manual and participant handouts for each session avail-
able in English and Spanish.
Peer specialists will be hired at each study site to de-
liver the Peer GLB intervention. Peer specialists must
have the following qualifications: GED/high school dip-
loma, lived experience managing an SMI, and comple-
tion of a peer specialist training program (e.g., Howiethe HARP Program in New York City). Peer specialist
training will include: 1) a 2-day GLB workshop for peer
specialists and their supervisors to learn how to deliver
the intervention; 2) twice a week post-workshop training
sessions for up to 3 months for peer specialists to ex-
perience an abridged version of GLB; 3) a workforce de-
velopment workshop to address issues of integrating
peer specialists into agency staff; and 4) mock practice
groups facilitated by peer specialists. During these mock
sessions, the study team will provide peer specialist feed-
back on their group facilitation skills, knowledge of the
intervention techniques, and competence completing
intervention tasks. We will also conduct professional de-
velopment workshops 2–3 times a year during the trial
to address any emerging issues related to the integration
of peer specialists into the workforce at each study site.
Usual care condition
Study sites offer services to help clients with their phys-
ical health through health promotion groups, linkages to
medical care, and community resources. These services
are of low intensity and focus mostly on health educa-
tion rather than skills building. Case managers at study
sites help clients connect with primary care physicians
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access to UC and we will track their use of UC services
at each assessment period.
Fidelity monitoring
We will monitor Peer GLB fidelity throughout the trial.
In weekly supervision meetings with peer specialists, the
researchers will review attendance logs and fidelity
scores, and use group problem-solving strategies to
troubleshoot any difficulties. GLB experts will also par-
ticipate in these supervision meetings on a monthly
basis. We will measure three elements of fidelity. Adher-
ence will be captured via fidelity checklists for each
group session that specify core session objectives and ac-
tivities. RAs will complete the checklists for each session
based on audio recordings of group sessions. Dose will
be calculated as the number of sessions each participant
attended during each intervention phase, measured via
attendance logs. Participant responsiveness intends to
examine clients’ views, experiences and satisfaction with
Peer GLB and will be captured using different methods.
First, RAs will review trial records to ascertain partici-
pants’ completion of intervention activities. Second, cli-
ents’ satisfaction with Peer GLB (see assessments below)
will be assessed at 6, 12, and 18 months as another indi-
cator of responsiveness. Third, up to 10 focus groups
with GLB participants will be conducted once they have
completed the 12-month intervention to explore their
views and reactions to the intervention. Focus groups
will consist of 8–10 participants, last 90 minutes, and
will be audio recorded and professionally transcribed. A
focus group guide with open-ended questions will be
used to elicit participants’ experiences with Peer GLB.
Procedures to handle treatment contamination
Several measures will be taken to minimize and monitor
treatment contamination given that participants’ ran-
domization will occur at the individual level within each
study site. Peer GLB sessions will be scheduled at differ-
ent times from other UC services to minimize interac-
tions between participants. During weekly supervision
meetings, peer specialists will be reminded about the ex-
perimental nature of the intervention and the import-
ance of not introducing Peer GLB content into other
activities at the agencies. To monitor contamination, we
will track all participants’ use of UC services in each of
our assessment periods. All participants will complete a
diffusion questionnaire at each assessment period that
contains items asking if they have discussed Peer GLB
topics (e.g., self-monitoring) with other participants.
Measures
Assessments will occur at baseline and at 6, 12, and 18
months post randomization. Bilingual RAs blinded toparticipants’ treatment condition will administer assess-
ments at the study sites via structured face-to-face inter-
views. Participants will receive US$25 and a round-trip
public transportation reimbursement at each assessment
period (see Table 2 for a description of effectiveness
study measures).
Data analysis for effectiveness trial
The distributions of all continuous variables will be
checked for normality and transformations will be
employed to normalize distributions, if necessary, before
applying parametric techniques. All tests will be 2-sided
with critical value α = 0.05. The distributions of demo-
graphic variables in both treatment arms will be exam-
ined and, if found to be unbalanced and associated with
treatment outcomes, will be included as covariates in all
models for those outcomes. A categorical indicator for
study sites will be included as a control variable in all
models. We will carry out all analyses on an intent-to-
treat (ITT) basis using all post-randomization data re-
gardless of whether the participant received or adhered
to treatment [74]. Missing data will be imputed, using
the MI and MIANALYZE procedures in SAS 9.2 (SAS
Institute, Cary, NC, USA). A 2010 national expert panel
[75] recommended sensitivity analyses for the impact of
missing data via pattern mixture models [76], which we
will conduct by investigating robustness of results to
perturbations of assumed values for missing data within
clinically plausibly ranges.
Analysis for Aim 1
Hypothesis 1: at 12 and 18 months post randomization,
there will be a larger percentage of Peer GLB subjects
compared to the UC group who have reached clinically
meaningful weight loss (≥5 % weight loss from baseline).
This hypothesis will be tested using logistic regression of
the dichotomous ≥ 5 % weight loss indicator at 12 and
18 months on treatment and control variables. Additional
tests of trend in percent weight loss will be performed
across all 3 follow-up times (6, 12, and 18 months) using
the generalized linear mixed-effects models described
below for secondary outcomes.
Analysis for Aim 2
Hypothesis 2: at 6, 12, and 18 months post randomi-
zation, there will be significant reductions in average
weight, waist circumference, and blood pressure and sig-
nificant improvements in physical activity, dietary behav-
iors, self-efficacy, recovery, and quality of life in Peer
GLB compared to UC. This hypothesis will be tested
with a generalized linear mixed-effects model [77]. Sep-
arate mixed models, adjusted for control variables, will
be fit for different outcomes. Dichotomous outcomes
will use a logistic link, while continuous outcomes will
Table 2 Effectiveness trial measures
Type of Variable Construct Description Timeline
Primary Outcome Weight Measured in lbs in light indoor clothing without shoes using a digital scale. B, 6, 12,18
Secondary Outcomes Anthropometrics Waist circumference measured to the nearest 0.1 cm with an anthropometric tape, in a horizontal plane 1 cm above
the navel in light indoor clothing. Blood pressure assessed on the right arm of participants after they rest quietly in a
seated position for at least 5 minutes, using a validated automated sphygmomanometer. Height measured without
shoes with an anthropometric tape to the nearest 0.1 cm at entry into the study. Body mass index: will be calculated
from measured height and weight (kg/m2)
B, 6, 12,18
Self-efficacy The Weight Efficacy Lifestyle (WEL) Questionnaire is a 20-item scale that asks people to rate their confidence to resist
eating in certain situations on a 10-point Likert scale ranging from 0 (not confident) to 9 (very confident) [90]. The
Multidimensional Health Locus of Control (MHLC) is a 24-item scale that measures the extent to which a participant
believes s/he has control over various aspects of their physical health [91]. These scales have established psychometrics
B, 6, 12,18
Physical activity The International Physical Activity Questionnaire (IPAQ) short form [92] (7 items) asks respondents the number of days
per week and the amount of time per day spent in vigorous and moderate activities and walking, during the 7 days
prior to the interview. It has established psychometrics, is available in English and Spanish, and is validated for people
with SMI [93]. The 6-Minutes Walking Test [94] will be used to measure the distance participants can walk in 6 minutes.
This measure has been used in previous health promotion trials with people with SMI [95]. An increase in distance of
more than 50 m has been linked to clinically significant reductions in risks for cardiovascular disease [94]
B, 6, 12,18
Dietary behaviors The Block Fat Screener and Fruit, Vegetable and Fiber Screener Questionnaires are brief food frequency measures that
provide valid assessments of the intake of these foods [96]. Three modules from the 2013 CDC Behavioral Risk Factors
Surveillance System Questionnaire: fruit and vegetable, drinks with sugar, and salt/sodium. These modules consist of 11
questions that measure eating behaviors in these areas [97]
B, 6, 12,18
Recovery The Recovery Assessment Scale [98] is a 24-item measure that captures different aspects of recovery and produces a
total recovery score and scores on 5 subscales
B, 6, 12,18
Quality of Life SF-12 [99], a self-report measure available in English and Spanish and validated among adults with SMI that generates
two summary scores for physical and mental health-related quality of life [100]
B, 6, 12,18
Moderators Demographics Self-reported age, gender, race/ethnicity, education, income, and marital status B
Psychiatric medications Self-reported list of psychiatric medications prescribed. Type and dosage will be recorded B, 6, 12,18
Attitudes toward Peer GLB Modified version of the Client Satisfaction Questionnaire, an 8-item self-report scale available in English and Spanish
to assess participants’ attitudes (e.g., satisfaction, acceptability) toward Peer GLB [101]
6, 12, 18
Mental health We will use the Revised Behavior and Symptom Identification Scale (BASIS-R) [102], a brief 24-item mental health severity
measure designed to assess depression/functioning, difficulty in interpersonal relationships, self-harm, emotional lability,
psychotic symptoms, and substance abuse. The BASIS-R is a reliable and valid measure that is sensitive to mental health
treatment and has been tested in persons with schizophrenia
B, 6, 12,18
Covariates Acculturation, barriers to
medical care, comorbid medical
conditions, service use and
alcohol/drug use
Acculturation: nativity, language preference, time in the US, age of migration. The Bidimensional Acculturation Scale [103],
a 24-item self-report measure that captures acculturation-related changes in two languages. Barriers to medical care: a list
of 11 common factors that may prevent patients from seeking medical care [104, 105]. Comorbid medical conditions: a list
of 17 common medical conditions by patient self-report. Service use: we will use established self-reported items from the
National Latino and Asian American Study/National Comorbidity Study-Replication to measure participants’ use of
mental/physical health services in the previous 6 months. This will help us track use of usual care services in the trial.
Substance abuse will be measured using a subset of questions from the Addiction Severity
Index (ASI) which assesses frequency of alcohol and drug use [106]
B, 6, 12,18
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to test this hypothesis will be as follows:
Model 1ð Þ : уijk ¼ αi þ βj ið Þ þ τk þ ατð Þik þ φþ єijk ;
where уijk is the outcome measure for jth subject in ith
treatment at time k = baseline, 6, 12, and 18 months; αi
is the treatment effect (Peer GLB or UC); βj(i) is the ran-
dom effect of subject j receiving treatment i; τk is the ef-
fect of time k; (ατ)ik is the treatment by time interaction;
φ represents any control variables including an indicator
of site; and єijk is the experimental error. It is assumed
that βj(i) are independent and identically distributed as
N(0, σb
2) for a fixed treatment i, єijk are independent and
identically distributed as N(0, σ2), and βj(i) and єijk are
mutually independent. We expect to find a significant
treatment-by-time interaction for all outcomes, with
Peer GLB participants having better health, recovery,
and quality of life than UC participants.
Analysis for Aim 3
We will explore interactions between treatment and socio-
demographics, use of antipsychotic medication, attitudes
toward peer specialists, and housing model (housing first
versus treatment first) by extending Model (1) above to in-
clude interaction terms between subgroup indicators,
treatment, and treatment by time. A significant three-way
interaction: for example, between gender, treatment, and
time would indicate differences in treatment outcome by
gender across time. Separate contrasts comparing the
treatment effect for men versus women will be formed at
each time point to identify and interpret where differences
occur. Because of the exploratory nature of these analyses
and the low power for identifying interactions coupled
with the multiple tests that will be done, caution will be
used when reporting all findings [78]. We will use appro-
priate statistical correction tests (e.g., Bonferroni-Dunn
test) to address the possibility of a Type 1 error that can
result from multiple testing. We will also include a medi-
ator analysis to explore how the different treatment fidel-
ity elements (e.g., adherence, dose) specified in our
conceptual model mediate Peer GLB effects on our pri-
mary and secondary outcomes.
Power analysis
The sample size of 300 was chosen to ensure sufficient
power (at least 80 %) of a 2-sided test with level of sig-
nificance α = 0.05 for detecting difference between Peer
GLB and UC with respect to the dichotomous primary
outcome of clinically meaningful weight loss (≥5 %
weight loss) at months 12 and 18. Prior studies have
demonstrated a 15 % difference between GLB and UC
(i.e., 38 % in GLB versus 23 % in UC) [27]. Assuming 10 %
attrition (i.e., n = 270) the current study will be able todetect with > 80 % power differences as small as 15 %
(e.g., 35 % in Peer GLB versus 20 % in UC) and even be
able to detect differences as small as 12.5 % if the clinically
meaningful weight loss in the UC group is low (e.g., only
10 % in UC). Attrition of 20 % (n = 240) provides power
> 80 % to detect differences as small as 16 %. All secondary
outcomes are measured on continuous scales. Using the
RMASS software (http://www.rmass.org/) to identify de-
tectable treatment effects sizes for repeated measures con-
trolling for site, we find that assuming attrition of 20 % by
18 months, there will be > 80 % power to detect effect sizes
as small as 0.25. A meta-analysis [23] found an average dif-
ference in percent weight loss between GLB-type inter-
ventions and UC of 4.1 % and an approximate standard
deviation of weight loss across studies of 8.8 %, indicating
an effect size of approximately 0.46. The current study
even with a conservative attrition of 30 % (n = 210) would
be able to detect this effect size with > 95 % power.
Mixed-methods implementation study (Aim 4)
The aims of this mixed-methods implementation study
are to: 1) characterize the outer/inner context of our
study sites before, during, and after the introduction of
Peer GLB; and 2) identify system-level, organizational-
level, and staff-level factors that facilitate or hinder Peer
GLB implementation. For this study, we will recruit
personnel from the study sites that represent different
levels of their organization (e.g., directors, providers).
Data for this implementation study will be collected be-
fore (Pre-randomized controlled trial (RCT)), during,
and after (Post-RCT) we conduct the effectiveness trial
(see Table 3).
Interviews with directors/program managers
Semi-structured qualitative interviews will be conducted
before and after the Peer GLB RCT with directors and pro-
gram managers to explore system-level and organizational-
level factors that could shape the implementation of Peer
GLB in supportive housing agencies. Directors will be
interviewed as key informants. They will also nominate
program managers who oversee health programs at their
respective agencies to participate in these interviews. A
structured interview guide informed by our conceptual
model will be used to elicit information about system-
level and organizational-level implementation factors that
could influence the implementation of Peer GLB. Inter-
views will be conducted by a trained RA, last approxi-
mately 90 minutes, and will be audio recorded and
professionally transcribed.
Surveys with direct service providers and peer specialists
Self-administered surveys will be conducted before and
after the Peer GLB RCT with direct service providers,
including peer specialists already employed at these
Table 3 Summary of mixed-methods implementation study
Methods Participants Projected
sample size






Agency directors and program managers 6 System-level and organizational-level
factors
X X
Surveys Direct service providers, including
peer specialists
45 Organizational-level and staff-level
factors
X X
Focus groups Direct service providers and
peer specialists





Agency directors, program managers,





NA not applicable, RCT randomized controlled trial
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implementation factors. The surveys will include mea-
sures of staff characteristics (e.g., work tenure) and the
following standardized instruments: Organizational So-
cial Context (OSC) to assess organizational culture, cli-
mate, and work attitudes [60]; Recovery Self-Assessment
(RSA) to capture organizations’ recovery orientation
[79]; and the Evidence-Based Practice Attitudes Scale
(EBPAS) [69] to examine attitudes towards EBP. Staff,
including peer specialists, at each site will complete the
survey during scheduled meetings with no upper man-
agers present, after receiving assurances of confidential-
ity and providing informed consent [60, 65].
Focus groups with direct service providers and peer
specialists
We will conduct focus groups (FGs) with direct service
providers, including peer specialists before and after the
Peer GLB RCT. Separate FGs for peer specialists and
non-peer staff will create a homogenous environment
during FG discussions and reduce reporting biases, since
some providers may supervise peer specialists. A FG
guide informed by our conceptual model will be used to
elicit views on the organization’s culture and climate, at-
titudes toward EBPs and Peer GLB, and experiences
implementing Peer GLB. FGs will be conducted after we
perform preliminary analyses of the staff surveys to cor-
roborate and/or expand the quantitative findings; a strat-
egy used in small mixed-method studies [80]. Each FG
will be composed of 8 participants, last 90 minutes, will
be audio recorded, and professionally transcribed.
Participant observation
Participant observation is a qualitative research method
in which researchers observe and/or take part in routine
activities and interactions of a group of people in order
to better understand their culture [81, 82]. Observations
are recorded in a systematic way through written field
notes [83]. For this project, participant observation willbe conducted to explore UC conditions at the agencies
before, during, and after the implementation of the
Peer GLB intervention and to examine system-level,
organizational-level, staff-level, and client-level factors
that could facilitate or hinder the implementation of
Peer GLB. Participant observation will also serve as an
opportunity to triangulate data collected through the
other methods used in this implementation study to
better understand the implementation process. Partici-
pant observation will focus on agency staff as they
carry out their usual activities and, during the imple-
mentation of Peer GLB, as they implement this inter-
vention. RAs will seek to observe naturally occurring
interactions and conversations among staff and clients
that can inform the implementation of Peer GLB and,
in later stages that can offer insight into agency con-
text after implementation.
Quantitative data analysis for implementation study
Given our small sample size of provider surveys (N = 45),
our quantitative analysis will be descriptive. We will calcu-
late frequencies for categorical variables and measures of
central tendencies for continuous variables. Since the
agency is the unit of analysis for this implementation
study, we will compute agency averages for our quantita-
tive measures noting discrepancies between non-peer staff
and peer specialists. We will use bivariate analysis (e.g., t
tests) to explore differences in agency scores on these
measures pre/post the Peer GLB RCT.
Qualitative data analysis for implementation study
Transcripts will be entered into Atlas.ti (http://atlasti.com/).
A grounded theory approach using open, axial, selective
and directive coding and the constant-comparative method
will inform the analysis [84]. We will use Atlas.ti to mark
instances where each code occurs in the data. We will use
established procedures to enhance the trustworthiness of
our analysis, including using multiple coders, triangulation
of data generated from multiple methods and respondents,
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with study sites, development of an audit trail, and
member-checking presentations [80].
Integration of qualitative and quantitative data
We will produce “thick descriptions” [85] of each
agency’s outer/inner contexts before and after the Peer
GLB RCT by triangulating findings from our different
methods. To do this, we will develop a thematic matrix
[86, 87] that includes agencies’ characteristics derived
from staff/peer specialist surveys (e.g., OSC profiles) and
emerging themes from our qualitative data organized by
the structural, organizational, and staff levels for each
agency pre/post Peer GLB implementation. The matrix
will be used to construct detailed organizational case
studies from the perspectives of agency leadership and
staff noting differences and similarities across contextual
levels and time. We will use the thematic matrix to
compare side-by-side system-level, organizational-level,
and staff-level factors for each agency that were identi-
fied as facilitating or hindering Peer GLB implementa-
tion. We will note common and unique factors for each
agency. This will generate a list of relevant system-level,
organizational-level, and staff-level factors and processes
organized by level of consensus (i.e., identified by more
than one source) and operational salience (i.e., identified
as critical for implementation). We will use this list to
generate a heuristic model to inform the development
of implementation strategies.
Discussion
Testing and implementing health interventions in com-
munity settings is critical for addressing the health dis-
parities faced by people with SMI. This study should
make several innovative contributions to the existing lit-
erature on the physical health of people with SMI. First,
it expands the use of an established intervention to a
new service setting not examined in previous health
intervention studies in order to reduce access barriers
and reach a diverse population with SMI. Second, it con-
tributes new knowledge about the health impacts (e.g.,
weight, blood pressure, levels of physical activity) of
peer-led interventions for people with SMI using a rigor-
ous effectiveness trial design. Third, it addresses the pau-
city of research examining the health of racially and
ethnically diverse people with SMI. Fourth, it provides
training and employment for people with SMI enabling
them to have a voice in shaping health care. Fifth, it pro-
vides an opportunity to explore the effectiveness and im-
plementation of Peer GLB in two commonly used
supportive housing models. The hybrid study design will
also produce policy-relevant information on the effect-
iveness and implementation of a novel peer-led healthy
lifestyle approach that can inform the allocation ofresources in the community to reduce premature mor-
tality among people with SMI. In all, this paper describes
the use of a hybrid research design that blends effective-
ness trial methodologies and implementation science
rarely used when studying the physical health of people
with SMI and can serve as a model for integrating im-
plementation science and health disparities research.
Trial status
Trial recruitment started in June 2015 and is currently
open.
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